Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e., non-genetic) exposures. Family history is the basis for many referrals to a genetic testing program, but family history is expected to depend on a person's age and family structure, the disease risk that is associated with BRCA1 and the sporadic disease risk in the population. Population-based research on BRCA1 is difficult to conduct because of logistic, financial and ethical issues. Methods: The first phase of the study created a simulation model of BRCA1 and breast/ovarian cancer in a family. The next phase analyzed the effects of age and pedigree size on the relationship between family history and whether someone carried a BRCA1 mutation...
OBJECTIVES: Epithelial ovarian cancer in women 40 years or younger is rare; diagnosis at this age ju...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
Background: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative ...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
Introduction: Selecting women affected with breast cancer who are most likely to carry a germline mu...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
The Department of Defense Familial Breast/Ovarian Cancer Research Project has offered genetic counse...
Cancer genetics services for the population of British Columbia, Canada are provided solely by the B...
OBJECTIVES: Epithelial ovarian cancer in women 40 years or younger is rare; diagnosis at this age ju...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
Background: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative ...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
Introduction: Selecting women affected with breast cancer who are most likely to carry a germline mu...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
The Department of Defense Familial Breast/Ovarian Cancer Research Project has offered genetic counse...
Cancer genetics services for the population of British Columbia, Canada are provided solely by the B...
OBJECTIVES: Epithelial ovarian cancer in women 40 years or younger is rare; diagnosis at this age ju...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...